Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (83 ops.)
Latest filing published 18 Sept 2026 for Revolution Medicines, Inc., €14k.
Filing timeline
BuySaleStephen Michael Kelsey
Insider track record
Disclosed buys
0
Disclosed sells
83
Signal history
Stephen Michael Kelsey: trading record in brief
On September 11, 2026, Stephen Michael Kelsey filed three sales at Revolution Medicines, Inc. that rank among the heaviest of the record: EUR 3,724,204, EUR 3,297,816 and EUR 3,149,568. In all the record holds 83 sales across 118 filings, worth EUR 34,583,029, with a median of EUR 119,816.
Filings were published from August 14, 2020 to September 18, 2026. The year 2020 gathers 45 of them, against 4 to 9 a year from 2021 to 2023, then 28 in 2024, 13 in 2025 and 14 in 2026. The rest is 29 option exercises and 6 grants, with no purchase.
Fifteen filings fall in the last twelve months, 12 of them sales. Grants and option exercises are counted apart from open-market trades. Publication delay is a median of 2 days. Within 30 days of colleagues at Revolution Medicines, Inc., Kelsey has 77, 72 and 64 own market trades, in that order. Every one in the same direction. Colleagues in order: Mark A. Goldsmith, Margaret A. Horn and Jack Anders.
Companies and markets linked to Stephen Michael Kelsey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations118 total
85 shares@ US$195.00740.0000% mcap0.1% of flowCommon StockSEC:0001462808-26-000010:0
5,484 shares@ US$199.30320.0028% mcap3.5% of flowCommon StockSEC:0001462808-26-000010:1
18,869 shares@ US$203.06060.0097% mcap11.0% of flowCommon StockSEC:0001462808-26-000007:6
52,500 shares@ US$42.450.0056% mcap6.4% of flowCommon StockSEC:0001462808-26-000007:0
40,031 shares@ US$40.740.0041% mcap4.7% of flowCommon StockSEC:0001462808-26-000007:1
800 shares@ US$198.55020.0004% mcap0.5% of flowCommon StockSEC:0001462808-26-000007:2
11,833 shares@ US$200.11450.0060% mcap6.8% of flowCommon StockSEC:0001462808-26-000007:3
13,368 shares@ US$200.77690.0068% mcap7.7% of flowCommon StockSEC:0001462808-26-000007:4
21,447 shares@ US$201.75070.011% mcap12.5% of flowCommon StockSEC:0001462808-26-000007:5
17,949 shares@ US$203.87260.0093% mcap10.5% of flowCommon StockSEC:0001462808-26-000007:7
4,995 shares@ US$204.84270.0026% mcap2.9% of flowCommon StockSEC:0001462808-26-000007:8
3,270 shares@ US$205.80750.0017% mcap1.9% of flowCommon StockSEC:0001462808-26-000007:9
4,302 shares@ US$99.48041.4% of flowCommon StockSEC:0001610717-26-000131:0
21,100 shares0Common StockSEC:0001610717-26-000083:0
5,447 shares@ US$76.81721.3% of flowCommon StockSEC:0001610717-25-000422:0
25,000 shares@ US$48.542.6% of flowCommon StockSEC:0001610717-25-000361:1
25,000 shares@ US$4.730.4% of flowCommon StockSEC:0001610717-25-000361:0
5,367 shares@ US$45.82490.8% of flowCommon StockSEC:0001610717-25-000350:0
44,059 shares@ US$43.584.0% of flowCommon StockSEC:0001610717-25-000339:1
55,941 shares@ US$44.485.2% of flowCommon StockSEC:0001610717-25-000339:2
25,000 shares@ US$4.730.2% of flowCommon StockSEC:0001610717-25-000339:3
23,682 shares@ US$45.922.3% of flowCommon StockSEC:0001610717-25-000339:4
1,318 shares@ US$46.930.1% of flowCommon StockSEC:0001610717-25-000339:5
100,000 shares@ US$4.731.5% of flowCommon StockSEC:0001610717-25-000339:0
4,289 shares@ US$39.830.5% of flowCommon StockSEC:0001610717-25-000238:0
25 of 118 declarations
